• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国前瞻性糖尿病研究(UKPDS)风险评估模型:II型糖尿病患者冠心病风险预测模型(UKPDS 56)

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

作者信息

Stevens R J, Kothari V, Adler A I, Stratton I M

机构信息

Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK.

出版信息

Clin Sci (Lond). 2001 Dec;101(6):671-9.

PMID:11724655
Abstract

A definitive model for predicting absolute risk of coronary heart disease (CHD) in male and female people with Type II diabetes is not yet available. This paper provides an equation for estimating the risk of new CHD events in people with Type II diabetes, based on data from 4540 U.K. Prospective Diabetes Study male and female patients. Unlike previously published risk equations, the model is diabetes-specific and incorporates glycaemia, systolic blood pressure and lipid levels as risk factors, in addition to age, sex, ethnic group, smoking status and time since diagnosis of diabetes. All variables included in the final model were statistically significant (P<0.001, except smoking for which P=0.0013) in likelihood ratio testing. This model provides the estimates of CHD risk required by current guidelines for the primary prevention of CHD in Type II diabetes.

摘要

目前尚未有用于预测 II 型糖尿病男性和女性患冠心病(CHD)绝对风险的确定性模型。本文基于来自 4540 名英国前瞻性糖尿病研究的男性和女性患者的数据,提供了一个用于估计 II 型糖尿病患者发生新的 CHD 事件风险的方程。与先前发表的风险方程不同,该模型是针对糖尿病的,除了年龄、性别、种族、吸烟状况和糖尿病诊断后的时间外,还将血糖、收缩压和血脂水平纳入为风险因素。最终模型中包含的所有变量在似然比检验中均具有统计学意义(P<0.001,吸烟除外,其 P = 0.0013)。该模型提供了当前 II 型糖尿病 CHD 一级预防指南所需的 CHD 风险估计值。

相似文献

1
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).英国前瞻性糖尿病研究(UKPDS)风险评估模型:II型糖尿病患者冠心病风险预测模型(UKPDS 56)
Clin Sci (Lond). 2001 Dec;101(6):671-9.
2
Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.弗雷明汉心血管风险方程和英国前瞻性糖尿病研究(UKPDS)风险评估模型对新诊断2型糖尿病患者冠心病的预后价值:一项英国研究的结果
Diabet Med. 2005 May;22(5):554-62. doi: 10.1111/j.1464-5491.2005.01494.x.
3
Prediction of 10-year coronary heart disease risk in Caribbean type 2 diabetic patients using the UKPDS risk engine.使用英国前瞻性糖尿病研究(UKPDS)风险评估引擎预测加勒比地区2型糖尿病患者10年冠心病风险。
Int J Cardiol. 2009 Mar 6;132(3):348-53. doi: 10.1016/j.ijcard.2007.12.005. Epub 2008 Jan 11.
4
A pen-and-paper coronary risk estimator for office use with patients with type 2 diabetes.一种供办公室使用的、适用于2型糖尿病患者的纸笔式冠心病风险评估工具。
Mayo Clin Proc. 2006 May;81(5):632-6. doi: 10.4065/81.5.632.
5
Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications.糖尿病患者的冠心病风险评估:英国前瞻性糖尿病研究(UKPDS)风险评估模型与弗雷明汉风险评估函数的比较及其临床意义
Diabet Med. 2004 Mar;21(3):238-45. doi: 10.1111/j.1464-5491.2004.01116.x.
6
Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population.英国2型糖尿病患者群体中主要冠心病事件预测评分的推导与验证
Diabetes Care. 2006 Jun;29(6):1231-6. doi: 10.2337/dc05-1911.
7
Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.弗雷曼特尔糖尿病研究中澳大利亚2型糖尿病患者的弗雷明汉心血管风险方程与英国前瞻性糖尿病研究心血管风险方程的比较。
Med J Aust. 2009 Feb 16;190(4):180-4. doi: 10.5694/j.1326-5377.2009.tb02684.x.
8
Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus.2型糖尿病患者冠心病总风险评分的制定与验证
Am J Cardiol. 2008 Mar 1;101(5):596-601. doi: 10.1016/j.amjcard.2007.10.019. Epub 2007 Dec 21.
9
Recalculation of cardiovascular risk score as a surrogate marker of change in clinical care of diabetes patients: the Alphabet POEM project (Practice Of Evidence-based Medicine).重新计算心血管风险评分作为糖尿病患者临床护理变化的替代指标:字母表POEM项目(循证医学实践)
Curr Med Res Opin. 2004 May;20(5):765-72. doi: 10.1185/030079904125003539.
10
Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine.预测 2 型糖尿病的大血管和微血管并发症:日本糖尿病并发症研究/日本老年糖尿病干预试验风险引擎。
Diabetes Care. 2013 May;36(5):1193-9. doi: 10.2337/dc12-0958. Epub 2013 Feb 12.

引用本文的文献

1
Artificial intelligence algorithm for predicting cardio-cerebrovascular risk in type 2 diabetes: concordance with clinical and instrumental assessments.预测2型糖尿病患者心脑血管风险的人工智能算法:与临床及仪器评估的一致性
Diabetol Metab Syndr. 2025 Aug 27;17(1):361. doi: 10.1186/s13098-025-01910-6.
2
2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association.《2025年韩国糖尿病管理临床实践指南:韩国糖尿病协会的建议》
Diabetes Metab J. 2025 Jul;49(4):582-783. doi: 10.4093/dmj.2025.0469. Epub 2025 Jul 1.
3
Patient perspectives on patient similarity-based risk communication for uncontrolled type 2 diabetes in primary care: A qualitative study.
初级保健中未控制的2型糖尿病患者对基于患者相似性的风险沟通的看法:一项定性研究。
PLoS One. 2025 Jul 2;20(7):e0327623. doi: 10.1371/journal.pone.0327623. eCollection 2025.
4
Implementation of Pharmacist Case-Finding and Care Pathway Intervention for Vascular Prevention (PROACT): Protocol for a Randomized Controlled Trial.药师血管预防病例发现与护理路径干预(PROACT)的实施:一项随机对照试验方案
CJC Open. 2025 Mar 20;7(6):821-831. doi: 10.1016/j.cjco.2025.03.011. eCollection 2025 Jun.
5
Characteristics of type 2 diabetes patients with overt cardiovascular diseases in Malaysia: the real-world evidence from the National Diabetes Registry.马来西亚2型糖尿病合并显性心血管疾病患者的特征:来自国家糖尿病登记处的真实世界证据。
BMC Res Notes. 2025 Apr 17;18(1):183. doi: 10.1186/s13104-025-07204-4.
6
Utility of a patient similarity-based digital tool for risk communication to patients with type 2 diabetes mellitus: perspectives from primary care physicians in ambulatory care.一种基于患者相似性的数字工具在向2型糖尿病患者进行风险沟通中的效用:门诊初级保健医生的观点
PLoS One. 2025 Mar 18;20(3):e0319992. doi: 10.1371/journal.pone.0319992. eCollection 2025.
7
Characterization of treatment intensified (add-on to metformin) adults with type 2 diabetes in Thailand: A cross-sectional real-world study (CONVERGE).泰国强化治疗(二甲双胍基础上加用其他药物)的2型糖尿病成人患者特征:一项横断面真实世界研究(CONVERGE)
J Diabetes Investig. 2025 Jun;16(6):1010-1019. doi: 10.1111/jdi.14409. Epub 2025 Mar 12.
8
Biomedical outcomes and cardiovascular risks in Chinese adults with type 2 diabetes in the metabolic management center program: A longitudinal comparative study.代谢管理中心项目中中国2型糖尿病成年患者的生物医学结局和心血管风险:一项纵向比较研究。
J Diabetes Investig. 2025 May;16(5):884-892. doi: 10.1111/jdi.14414. Epub 2025 Feb 1.
9
Overcoming Missing Data: Accurately Predicting Cardiovascular Risk in Type 2 Diabetes, A Systematic Review.克服数据缺失:2型糖尿病心血管风险的准确预测,一项系统评价
J Diabetes. 2025 Jan;17(1):e70049. doi: 10.1111/1753-0407.70049.
10
Cardiovascular Risk Prediction Scores in Type 1 Diabetes: A Systematic Review and Meta-Analysis.1型糖尿病的心血管风险预测评分:一项系统评价和荟萃分析
JACC Adv. 2024 Dec 17;4(1):101462. doi: 10.1016/j.jacadv.2024.101462. eCollection 2025 Jan.